Linden Capital To Acquire SeraCare For $4/Share
SeraCare Life Sciences Inc (NASDAQ: SRLS) agreed to be bought by Linden Capital Partners for $4 per share.
SeraCare's board had approved the terms of the deal. The offer price represents a 19% premium to the closing price of $3.37 on Friday.
SRLS shares gained 6.23% to close at $3.58 on Friday.







